Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Solution To Panel Dilemma Will Not Require New Contak Implants

This article was originally published in The Gray Sheet

Executive Summary

Guidant's Contak CD "continued access policy" IDE could augment the company's pivotal trial and allow the firm to avoid returning for a second review by the Circulatory System Devices Panel.

You may also be interested in...



COMPANION Results Will Better Define Resynch ICD Population – NEJM

Congestive heart failure patients that are symptomatic due to ischemic cardiomyopathy and a wide QRS complex may be appropriate candidates for resynchronization therapy combined with a defibrillator, an editorial appearing in the June 13 New England Journal of Medicine suggests

COMPANION Results Will Better Define Resynch ICD Population – NEJM

Congestive heart failure patients that are symptomatic due to ischemic cardiomyopathy and a wide QRS complex may be appropriate candidates for resynchronization therapy combined with a defibrillator, an editorial appearing in the June 13 New England Journal of Medicine suggests

Resynchronization Therapy Compromised By ICD Backup, Saxon Tells NASPE

Resynchronization therapy with an implantable defibrillator backup undermines the salutary effect of bi-ventricular pacing for congestive heart failure, according to Leslie Saxon, MD, University of California at San Francisco.[Editors' note: Please see the attached June 6 letter to "The Gray Sheet" from Saxon commenting on the context of her presentation at NASPE. The presentation, Saxon says, should not have been reported literally.]

Related Content

UsernamePublicRestriction

Register

MT015149

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel